2m 2m 2m 2m 2m 2m 2m
IMMUNOME (IMNM)
NASDAQ
$19.00-$0.18 (-0.93%)
Price as of Jun 23, 2026 6:09 PM EDT- $2.2BMarket Cap
- 119.45%1-Year Change
- BiotechnologyIndustry
IMMUNOME (IMNM)
$19.00-$0.18 (-0.93%)
IMNM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $19.18 | ||
Change | +$0.44 (+2.35%) | ||
Open | $19.02 | ||
High | $19.66 | ||
Low | $19.02 | ||
Previous Close | $18.74 | ||
Volume | 1,232,773 | ||
30-Day Average Volume | 1,406,270 | ||
1-Week Change | 6.14% | ||
1-Month Change | -11.45% | ||
1-Year Change | 119.45% | ||
3-Year Change | 258.50% | ||
5-Year Change | 14.03% | ||
Fundamentals | |||
Shares Outstanding | 113.3M | ||
Total Assets | $619.8M | ||
Market Cap | $2.2B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$53.8M | ||
Free Cash Flow | -$61.6M | ||
EBIT | -$53.8M | ||
EBITDA | -$53.2M | ||
Net Working Capital | $566.9M | ||
EPS | -$0.48 | ||
Enterprise Value/EBITDA | -30 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -40 | ||
PEG | -1 | ||
Price/Free Cash Flow | -35 | ||
Price/Operating Cash Flow | -37 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 1000 | ||
Last Split Date | 12/19/2007 | ||
Earnings & Revenue